Related references
Note: Only part of the references are listed.DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer
Andrew Stone et al.
NATURE COMMUNICATIONS (2015)
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
Van T. M. Nguyen et al.
NATURE COMMUNICATIONS (2015)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2015)
Mechanisms of aromatase inhibitor resistance
Cynthia X. Ma et al.
NATURE REVIEWS CANCER (2015)
D538G Mutation in Estrogen Receptor-α: A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer
Keren Merenbakh-Lamin et al.
CANCER RESEARCH (2013)
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
Weiyi Toy et al.
NATURE GENETICS (2013)
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
Dan R. Robinson et al.
NATURE GENETICS (2013)
Discovering high-resolution patterns of differential DNA methylation that correlate with gene expression changes
Nathan D. VanderKraats et al.
NUCLEIC ACIDS RESEARCH (2013)
Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
Shunqiang Li et al.
CELL REPORTS (2013)
The Prostanoid EP4 Receptor and Its Signaling Pathway
Utako Yokoyama et al.
PHARMACOLOGICAL REVIEWS (2013)
Scriptaid effects on breast cancer cell lines
L. Giacinti et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Expression Profiling after Induction of Demethylation in MCF-7 Breast Cancer Cells Identifies Involvement of TNF-α Mediated Cancer Pathways
Ju Hee Kim et al.
MOLECULES AND CELLS (2012)
Functional Activation of the Estrogen Receptor-α and Aromatase by the HDAC Inhibitor Entinostat Sensitizes ER-Negative Tumors to Letrozole
Gauri J. Sabnis et al.
CANCER RESEARCH (2011)
A Gene Expression Signature from Human Breast Cancer Cells with Acquired Hormone Independence Identifies MYC as a Mediator of Antiestrogen Resistance
Todd W. Miller et al.
CLINICAL CANCER RESEARCH (2011)
Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor-Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype-ACOSOG Z1031
Matthew J. Ellis et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer
Cesar G. Sanchez et al.
BREAST CANCER RESEARCH (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
Identification of EP4 as a Potential Target for the Treatment of Castration-Resistant Prostate Cancer Using a Novel Xenograft Model
Naoki Terada et al.
CANCER RESEARCH (2010)
CARM1 mediates the ligand-independent and tamoxifen-resistant activation of the estrogen receptor α by cAMP
Sophie Carascossa et al.
GENES & DEVELOPMENT (2010)
Chromatin and sequence features that define the fine and gross structure of genomic methylation patterns
John R. Edwards et al.
GENOME RESEARCH (2010)
Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
Mitch Dowsett et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Biological reprogramming in acquired resistance to endocrine therapy of breast cancer
H. Aguilar et al.
ONCOGENE (2010)
TopHat: discovering splice junctions with RNA-Seq
Cole Trapnell et al.
BIOINFORMATICS (2009)
Inhibition of histone deacetylase suppresses EGF signaling pathways by destabilizing EGFR mRNA in ER-negative human breast cancer cells
Qun Zhou et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor-Positive Breast Cancer
Robert J. Crowder et al.
CANCER RESEARCH (2009)
Improved Surgical Outcomes for Breast Cancer Patients Receiving Neoadjuvant Aromatase Inhibitor Therapy: Results from a Multicenter Phase II Trial
John A. Olson et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2009)
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores
Rafael A. Irizarry et al.
NATURE GENETICS (2009)
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
Chad J. Creighton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Biological determinants of endocrine resistance in breast cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2009)
Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer
Elizabeth Iorns et al.
CANCER CELL (2008)
Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics
Matthew J. Ellis et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Phosphorylation of estrogen receptor alpha, serine residue 305 enhances activity
Robin Tharakan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells
Asmaa Fritah et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
MethyIScreen: DNA methylation density monitoring using quantitative PCR
H. Holemon et al.
BIOTECHNIQUES (2007)
Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis
XR Ma et al.
CANCER RESEARCH (2006)
The epigenetic progenitor origin of human cancer
AP Feinberg et al.
NATURE REVIEWS GENETICS (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A novel histone deacetylase inhibitor, Scriptaid, enhances expression of functional estrogen receptor α (ER) in ER negative human breast cancer cells in combination with 5-aza 2′-deoxycytidine
JC Keen et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Aromatase inhibitors for breast cancer: Lessons from the laboratory
SRD Johnston et al.
NATURE REVIEWS CANCER (2003)
Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation
CMW Chan et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2002)
Involvement of cyclic AMP response element binding protein (CREB) and estrogen receptor phosphorylation in the synergistic activation of the estrogen receptor by estradiol and protein kinase activators
G Lazennec et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2001)
Share Paper
